How significant is the 18,010-share tax withholding for HealthEquity (HQY) investors?

The 18,010-share tax withholding is a routine administrative event tied to equity compensation. Such transactions are common for executives and generally carry limited informational value, especially since Rosner continues to hold 86,265 HealthEquity shares directly after the disposition.

HealthEquity (NASDAQ: HQY) CTO has 18,010 shares withheld for taxes

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

HealthEquity, Inc. executive Elimelech Rosner, EVP and Chief Technology Officer, reported a Form 4 transaction involving tax withholding of company shares. On this date, 18,010 shares of Common Stock were disposed of at an average of $82.5264 per share to cover tax obligations. After this non‑market tax-withholding disposition, Rosner directly holds 86,265 shares of HealthEquity common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rosner Elimelech

Role EVP, CHIEF TECHNOLOGY OFFICER

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	18,010	$82.5264	$1.49M

Holdings After Transaction: Common Stock — 86,265 shares (Direct)

Footnotes (1)

Key Figures

Tax-withholding shares: 18,010 shares Average price per share: $82.5264 per share Shares held after transaction: 86,265 shares

3 metrics

Tax-withholding shares 18,010 shares Common Stock disposed in code F tax-withholding

Average price per share $82.5264 per share Value used for 18,010-share tax-withholding disposition

Shares held after transaction 86,265 shares Rosner’s direct HealthEquity Common Stock holdings post-transaction

Key Terms

Form 4, tax-withholding disposition, Common Stock

3 terms

Form 4 regulatory

"Elimelech Rosner reported a Form 4 transaction involving tax withholding of company shares."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

tax-withholding disposition financial

"reported a Form 4 transaction involving tax withholding of company shares."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

"18,010 shares of Common Stock were disposed of at an average of $82.5264 per share"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 05:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rosner Elimelech

(Last)

(First)

(Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER

UTAH

84020

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, CHIEF TECHNOLOGY OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		F		18,010	D	$82.5264	86,265	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

The Power of Attorney given by Mr. Rosner was previously filed with the U.S. Securities and Exchange Commission on July 7, 2023, as an exhibit to a statement on Form 4 filed by Mr. Rosner with respect to HealthEquity, Inc. and is hereby incorporated by reference.

	/s/ Michael Newton, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HealthEquity (HQY) CTO Elimelech Rosner report?

Elimelech Rosner reported a tax-withholding disposition of shares, not an open-market trade. On the reported date, 18,010 shares of HealthEquity Common Stock were withheld to cover tax obligations associated with equity compensation, while he retained a substantial remaining direct shareholding.

How many HealthEquity (HQY) shares were withheld for taxes in this Form 4?

The Form 4 shows 18,010 shares of HealthEquity Common Stock were disposed of as a tax-withholding event. These shares were valued at an average of $82.5264 per share, reflecting shares delivered to satisfy tax liabilities rather than a discretionary market sale.

What does transaction code F mean in the HealthEquity (HQY) Form 4?

Transaction code F indicates payment of an exercise price or tax liability by delivering securities. Here, it reflects a tax-withholding disposition, where 18,010 HealthEquity shares were surrendered to cover taxes tied to equity awards, not a voluntary open-market purchase or sale.

How many HealthEquity (HQY) shares does Elimelech Rosner hold after this transaction?

After the tax-withholding disposition, Elimelech Rosner directly holds 86,265 shares of HealthEquity Common Stock. This post-transaction balance reflects his ongoing equity stake as EVP and Chief Technology Officer, following the delivery of shares to satisfy personal tax obligations.

Was this HealthEquity (HQY) insider transaction a market sale of shares?

No, the filing describes a tax-withholding disposition rather than an open-market sale. Shares labeled with code F were delivered to cover tax liabilities arising from equity compensation, meaning the transaction does not represent a discretionary decision to sell shares on the market.